Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Four Lots of Quinapril Tablets Due to Potential Presence of N-Nitroso-Quinapril Impurity


Lupin Pharmaceuticals Inc. is voluntarily recalling four (4) lots of Quinapril Tablets to the patient (consumer/user) level due to the presence of a nitrosamine impurity, N-Nitroso-Quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level. To date, Lupin has received no rep (US Food Recalls) More More

Similar stories

An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine ... - ScienceDirect.com

An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine ...  ScienceDirect.com

Posted on 24 December 2022 | 4:29 am | Google News

Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Four Lots of Quinapril Tablets due to potential ... - PR Newswire

Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Four Lots of Quinapril Tablets due to potential ...  PR Newswire

Posted on 21 December 2022 | 3:00 am | Google News

Quinapril Tablets Recalled Due to Nitrosamine Impurity - Monthly Prescribing Reference

Quinapril Tablets Recalled Due to Nitrosamine Impurity  Monthly Prescribing Reference

Posted on 21 December 2022 | 3:00 am | Google News

Copyright © 2024 LastMinuteStuff.com | Contact info